COMMUNIQUÉS West-GlobeNewswire

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device
08/10/2025
40-Hz DIFS™ significantly improves cognitive performance and brain connectivity in peer-reviewed clinical trial Results published in Radiology, the flagship journal of the Radiological Society of North America (RSNA) [...]
Sapu Nano Unveils First-in-Human Clinical Trial of Sapu-003 at 8th Australian Translational Breast Cancer Research Symposium
08/10/2025
Using Sapu Nano’s proprietary Deciparticle™ technology, Sapu-003 delivers everolimus intravenously SYDNEY, Australia, Oct. 08, 2025 (GLOBE NEWSWIRE) -- via IBN – Sapu Nano today announced the presentation of its poster [...]
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting
08/10/2025
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post PRINCETON, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical [...]
Journey Medical Corporation to Participate in October 2025 Investor Conferences
08/10/2025
SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing [...]
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
08/10/2025
SARASOTA, FL, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced its [...]
PharmAla Launches Nexus Portal for MDMA Prescribers and Therapists
08/10/2025
TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Pluri Subsidiary Coffeesai and Instituto del Café de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico
08/10/2025
State - backed collaboration outlines a multi - phase, capital - light path from cell line development to pilot - scale biofarming and evaluation of commercial - scale manufacturing in Chiapas Coffeesai leverages Pluri’ [...]
SCIENTURE Holdings Announces Full Repayment and Conversion of Outstanding Debentures, Strengthening Balance Sheet
08/10/2025
COMMACK, NY, Oct. 08, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, [...]
Zarminali Pediatrics Welcomes New Chief Technology Officer to Advance Patient-Centric Connected Care Model
08/10/2025
Syed Hassan has joined the national pediatric group to scale technology that will enhance coordinated experiences for patients, parents, and providers nationwide CHICAGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Zarminali [...]
Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water
08/10/2025
New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to [...]
NewGen Establishes New Joint Venture Dedicated to Real Estate Development in UAE
08/10/2025
An agreement signed between NewGen and BNW will establish a joint venture to develop NewGen’s recently acquired plot of land in Ras Al Khaimah’s Beach District, UAE Feasibility studies indicate potential net returns for [...]
VIVUS Announces QSYMIA® Price Reduction at Costco Pharmacies Nationwide
08/10/2025
— Lowered price at retail pharmacy to expand access to overweight or obesity treatment to more patients CAMPBELL, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the [...]
GT Biopharma Provides Enrollment Update on GTB-3650 Phase 1 Trial in Patients with Relapsed or Refractory (r/r) CD33 Expressing Hematologic Malignancies
08/10/2025
The Company is well on track with Phase 1 enrollment now that both patients in Cohort 3 have successfully initiated treatment with no evidence of dose-limiting toxicities or tolerability concerns to date The first [...]
Mainz Biomed Reports Topline Results from Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
08/10/2025
Study Demonstrated a Sensitivity of 100% and Specificity of 95% Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, [...]
Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy
08/10/2025
Investment creates the world’s first Strategic Compute Reserve Strategy complements Predictive Oncology’s AI/ML-driven drug discovery and development activities PITTSBURGH, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Predictive [...]
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
08/10/2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA [...]
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
08/10/2025
Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date MENLO PARK, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB [...]
Intuitive expands AI and advanced imaging integration in Ion Endoluminal System
08/10/2025
FDA-cleared software release enhances navigation and broadens access to advanced imaging for lung biopsy procedures SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology [...]
InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow
08/10/2025
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA [...]

Pages